Abnormal Liver Blood Tests: Primary Care Approach

Area of Science:

• Hepatology
• Primary Care Medicine
• Epidemiology

Background:

• Annual liver disease deaths show a dramatic increase, with projections indicating continued upward trends.
• Nonalcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ARLD) are increasingly significant contributors to liver disease burden.
• Viral hepatitis management has improved, shifting the primary drivers of liver disease to NAFLD and ARLD.

Purpose of the Study:

• To highlight the increasing prevalence of liver disease and its primary causes.
• To emphasize the critical role of primary care in evaluating abnormal liver blood tests.
• To guide the assessment of patients with potential liver disease in primary care settings.

Main Methods:

• Review of epidemiological data on liver disease mortality trends.
• Analysis of common causes of elevated transaminase levels in the general population.
• Recommendations for diagnostic evaluation in primary care, including history, specific testing, and imaging.

Main Results:

• Mildly elevated transaminase levels affect 10-20% of the general population.
• NAFLD and ARLD are the leading causes of rising liver disease burden.
• Silent progression of liver disease is common, often leading to cirrhosis before detection.

Conclusions:

• Abnormal liver blood tests are a frequent primary care challenge requiring thorough etiological evaluation.
• Primary care physicians play a vital role in screening at-risk individuals and referring those with advanced disease.
• Comprehensive evaluation including alcohol history, medication review, viral hepatitis screening, NAFLD assessment, and abdominal ultrasound is recommended.